ERBB2 and breast cancer: Given the immense therapeutic opportunities offered by cell-membrane proteins64–66, the detected RTKs, GPCRs, CD antigens, MMPs, adhesion and transport proteins were searched in the DrugBank database to identify prospects for targeting HER2+ breast cancer cells64.